CRVS short interest
Corvus Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,797,751 |
|---|---|
| Change vs prior report | 617,410 (+3.6%) |
| Change over six months | +5.0% |
| Days to cover | 13.31 (sector: 3.78) |
| Average daily volume | 1,336,813 |
| Rank in Healthcare | #52 of 922 by days to cover |
CRVS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,797,751 | +3.6% | 13.31 | 1,336,813 |
| 2026-09-15 | 17,180,341 | -9.7% | 18.16 | 946,307 |
| 2026-08-31 | 19,017,840 | -0.6% | 29.64 | 641,670 |
| 2026-08-14 | 19,127,098 | +4.5% | 22.53 | 849,105 |
| 2026-07-31 | 18,310,256 | +1.4% | 22.50 | 813,944 |
| 2026-07-15 | 18,061,919 | -4.0% | 12.59 | 1,434,623 |
| 2026-06-30 | 18,819,891 | +5.2% | 12.38 | 1,520,069 |
| 2026-06-15 | 17,882,834 | +3.2% | 14.37 | 1,244,138 |
| 2026-05-29 | 17,324,311 | -8.4% | 8.45 | 2,051,054 |
| 2026-05-15 | 18,910,283 | +2.9% | 11.98 | 1,579,015 |
| 2026-04-30 | 18,385,941 | +8.6% | 11.54 | 1,593,299 |
| 2026-04-15 | 16,928,111 | -0.1% | 21.77 | 777,574 |
| 2026-03-31 | 16,951,894 | +5.6% | 11.09 | 1,528,575 |
| 2026-03-13 | 16,054,916 | +0.3% | 14.71 | 1,091,580 |
| 2026-02-27 | 16,009,857 | +7.6% | 13.29 | 1,205,016 |
| 2026-02-13 | 14,883,150 | +1.4% | 9.81 | 1,517,092 |
| 2026-01-30 | 14,678,521 | +27.8% | 1.09 | 13,502,350 |
| 2026-01-15 | 11,486,255 | -2.8% | 7.54 | 1,524,014 |
| 2025-12-31 | 11,816,663 | +25.9% | 6.47 | 1,825,586 |
| 2025-12-15 | 9,383,518 | -4.4% | 6.71 | 1,397,824 |
| 2025-11-28 | 9,812,924 | -0.9% | 12.97 | 756,405 |
| 2025-11-14 | 9,902,822 | +9.7% | 8.72 | 1,135,166 |
| 2025-10-31 | 9,028,415 | +2.2% | 8.88 | 1,016,507 |
| 2025-10-15 | 8,833,502 | -12.5% | 7.85 | 1,124,607 |
| 2025-09-30 | 10,096,570 | +4.4% | 12.64 | 798,741 |
import finzdata as yf
yf.Ticker("CRVS").short_interest # every report since 2017
yf.Client().short_interest(["CRVS"], start="2018-01-01")Healthcare short interest · CRVS price history · Who owns CRVS · All short interest